Quick Answer
Arcturus Therapeutics Holdings Inc. reported Revenue From Contract With Customer Excluding Assessed Tax of $82.03 million for the year ending 2025.
- Arcturus Therapeutics Holdings Inc. showed a decrease of -46.1% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from Arcturus Therapeutics Holdings Inc.'s annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2018 to 2025 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 8 years of available data (2018 to 2025), Arcturus Therapeutics Holdings Inc.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 420.7%.
- Historical annual values: Fiscal year 2025: $82.03 million | Fiscal year 2024: $152.31 million | Fiscal year 2023: $166.80 million | Fiscal year 2022: $206.00 million | Fiscal year 2021: $12.36 million | Fiscal year 2020: $9.54 million | Fiscal year 2019: $20.79 million | Fiscal year 2018: $15.75 million.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: